Discover 241 paid clinical trials in Spokane, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 241
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for
Breast Cancer
Location: Spokane WA, Spokane Valley WA, Issaquah WA, Kirkland WA,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06492616
Phase3, Recruiting
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
for
Amblyopia
Location: Spokane WA, Seattle WA, Portland OR, Sacramento CA,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 4 - 7
Code: NCT06380517
Phase3, Recruiting
Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM
for
Epiretinal Membrane
Location: Spokane WA, Eugene OR, Sacramento CA, Oakland CA,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 50+
Code: NCT05145491
Recruiting
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
for
Geographic Atrophy, Macular Degeneration
Location: Spokane WA, Eugene OR, Salt Lake City UT, Reno NV,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 60+
Code: NCT06635148
Phase2, Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
for
Amblyopia
Location: Spokane WA, Portland OR, Albany OR, Sacramento CA,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 8 - 12
Code: NCT06524882
Phase3, Recruiting
Clarifying the Optimal Application of SLT Therapy Trial
for
Glaucoma and Ocular Hypertension
Location: Spokane WA, Portland OR, Sacramento CA,
Sponsor: University of Pittsburgh
Sex: All
Age: 18+
Code: NCT04967989
Phase3, Recruiting
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy